Related Experiment Videos

The signal averaged P wave in atrioventricular block--evidence for abnormal atrial conduction?

P J Stafford1, J Cooper, S Baker

  • 1Academic Department of Cardiology, Glenfield General Hospital, Leicester, UK.

Insights

Patients with atrioventricular block (AVB) and pacemakers show abnormal atrial activation, increasing atrial fibrillation risk. This suggests intrinsic atrial issues, not just pacing, contribute to fibrillation incidence.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Biomedical Engineering

Background:

  • Atrial fibrillation (AF) incidence is higher in patients with atrioventricular block (AVB), even with dual-chamber pacing.
  • The role of concurrent atrial activation abnormalities in AF development in AVB patients requires further investigation.

Purpose of the Study:

  • To assess if atrial activation abnormalities contribute to the increased incidence of atrial fibrillation in patients with AVB and pacemakers.
  • To compare signal-averaged P wave (SAPW) recordings in paced AVB patients versus unpaced controls.

Main Methods:

  • Signal-averaged P wave (SAPW) recordings were performed in 15 patients with dual-chamber pacemakers for AVB and 21 unpaced controls.
  • Measurements included P wave duration, spatial velocity, and spectral energy (Fourier transformation).
  • Analysis focused on differences in these parameters between the AVB and control groups.

Main Results:

  • Patients with AVB exhibited significantly increased P wave duration (144 ms vs. 134 ms).
  • Mean spatial velocity was higher in AVB patients (5.6 mV/s vs. 4.6 mV/s).
  • Lower frequency spectral energy (20-150 Hz) was significantly greater in the AVB group (57.4 μV².s vs. 36.3 μV².s).

Conclusions:

  • Intrinsic abnormalities in atrial activation are suggested in patients paced for AVB.
  • These findings indicate that atrial fibrillation in this population may stem from underlying atrial issues, not solely pacing mode.
  • Sequential atrioventricular pacing might not fully mitigate the elevated risk of atrial fibrillation.

Related Concept Videos